PIA
GILD icon

Peachtree Investment Advisors’s Gilead Sciences GILD Stock Holding History

Peachtree Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-18,100
Closed -$1.71M – 332
2014
Q4 		$1.71M Buy
+18,100
New +$1.87M 1.14% 17

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Peachtree Investment Advisors's GILD Position: Q1 2015 in Review

Peachtree Investment Advisors sold out of Gilead Sciences (GILD) in Q1 2015, closing a stake of 18,100 shares — an estimated $1.71M sold.

Peachtree Investment Advisors first reported a position in GILD in Q4 2014 and held it in 1 quarter. The position peaked at $1.71M in Q4 2014. 1,493 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

  • Peachtree Investment Advisors reported no remaining Gilead Sciences position as of Q1 2015 after selling out during the quarter.
  • Peachtree Investment Advisors sold 18,100 Gilead Sciences shares in Q1 2015, an estimated $1.71M.
  • Peachtree Investment Advisors first reported a position in Gilead Sciences in Q4 2014 and held it in 1 quarter.
  • Peachtree Investment Advisors's Gilead Sciences position peaked at $1.71M in Q4 2014.
  • 1,493 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Peachtree Investment Advisors's 13F filing for Q1 2015, filed 14 Apr 2015.